Literature DB >> 11606721

The kinetic basis of peptide exchange catalysis by HLA-DM.

J A Zarutskie1, R Busch, Z Zavala-Ruiz, M Rushe, E D Mellins, L J Stern.   

Abstract

The mechanism by which the peptide exchange factor HLA-DM catalyzes peptide loading onto structurally homologous class II MHC proteins is an outstanding problem in antigen presentation. The peptide-loading reaction of class II MHC proteins is complex and includes conformational changes in both empty and peptide-bound forms in addition to a bimolecular binding step. By using a fluorescence energy transfer assay to follow the kinetics of peptide binding to the human class II MHC protein HLA-DR1, we find that HLA-DM catalyzes peptide exchange by facilitating a conformational change in the peptide-bound complex, and not by promoting the bimolecular MHC-peptide reaction or the conversion between peptide-receptive and -averse forms of the empty protein. Thus, HLA-DM serves essentially as a protein-folding or conformational catalyst.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606721      PMCID: PMC60074          DOI: 10.1073/pnas.211439398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Determination of the HLA-DM interaction site on HLA-DR molecules.

Authors:  R C Doebele; R Busch; H M Scott; A Pashine; E D Mellins
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

2.  The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

Authors:  L J Stern; D C Wiley
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

3.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.

Authors:  J M Riberdy; J R Newcomb; M J Surman; J A Barbosa; P Cresswell
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

4.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant.

Authors:  A Sette; S Ceman; R T Kubo; K Sakaguchi; E Appella; D F Hunt; T A Davis; H Michel; J Shabanowitz; R Rudersdorf
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

5.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.

Authors:  P A Roche; P Cresswell
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

7.  A kinetic intermediate in the reaction of an antigenic peptide and I-Ek.

Authors:  S Sadegh-Nasseri; H M McConnell
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

Review 8.  MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

Authors:  R N Germain
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

9.  An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.

Authors:  P Morris; J Shaman; M Attaya; M Amaya; S Goodman; C Bergman; J J Monaco; E Mellins
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

10.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  35 in total

1.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

3.  Small molecules that enhance the catalytic efficiency of HLA-DM.

Authors:  Melissa J Nicholson; Babak Moradi; Nilufer P Seth; Xuechao Xing; Gregory D Cuny; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 4.  The convergent roles of tapasin and HLA-DM in antigen presentation.

Authors:  Scheherazade Sadegh-Nasseri; Mingnan Chen; Kedar Narayan; Marlene Bouvier
Journal:  Trends Immunol       Date:  2008-02-07       Impact factor: 16.687

5.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

7.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

8.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.

Authors:  Zemin Zhou; Kari A Callaway; Dominique A Weber; Peter E Jensen
Journal:  J Immunol       Date:  2009-10-01       Impact factor: 5.422

Review 10.  Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.